Vertex Pharmaceuticals Incorporated (VX1) Short Interest
DB • VX1 • US92532F1003
As of Nov 3, 2026, ORTEX estimates 0.1% of free float is sold short, 5,309.1 days to cover, cost to borrow 0.48%.
DB • VX1 • US92532F1003
As of Nov 3, 2026, ORTEX estimates 0.1% of free float is sold short, 5,309.1 days to cover, cost to borrow 0.48%.
This page tracks how heavily Vertex Pharmaceuticals Incorporated (DB:VX1) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Vertex Pharmaceuticals Incorporated (DB: VX1) has a market capitalization of $139.2B. Last close €478.60 (as of 2026-11-05); 52-week range €353.70 to €500.50. ORTEX data as of 2026-11-03: short interest is 0.12% of free float, 5,309.1 days to cover and the average cost to borrow is 0.48%.